Our in vitro and in vivo assays suggest that CD133+ cells derived from DMD muscle have a compromised capacity to contribute to muscle regeneration and that this may be related to their low myogenic capacity in vitro. This evidence concerns the gene PROM1 and Duchenne muscular dystrophy.